Type-2 diabetes mellitus remission prediction models after Roux-En-Y gastric bypass and sleeve gastrectomy based on disease severity scores [0.03%]
基于疾病严重程度分数的Roux-en-Y胃旁路手术和袖状胃切除术后2型糖尿病缓解预测模型
Wissam Ghusn,Karl Hage,Robert A Vierkant et al.
Wissam Ghusn et al.
Aim: Metabolic and bariatric surgery (MBS) is considered one of the most effective interventions for weight loss and associated type-2 diabetes mellitus (T2DM) remission. Multiple scores including the Individualized Metab...
COX2 inhibitor use and type 2 diabetes treatment intensification: A registry-based cohort study [0.03%]
COX2抑制剂的使用与二型糖尿病强化治疗：一项基于注册信息的队列研究
George S Q Tan,Jedidiah I Morton,Stephen Wood et al.
George S Q Tan et al.
Aim: This study examined the association between cyclooxygenase-2 inhibitor (COX2i) use and diabetes progression in people with type 2 diabetes. Methods: ...
The association between antidepressant treatment and rates of insulin initiation in comorbid depression and type 2 diabetes: A UK electronic health record nested case-control study [0.03%]
抗抑郁药治疗与合并抑郁症和二型糖尿病患者胰岛素启动率之间的关联：一项英国电子健康记录嵌套病例对照研究
Annie Jeffery,Kate Walters,Ian C K Wong et al.
Annie Jeffery et al.
Aims: To investigate the association between antidepressant prescribing and the rate of insulin initiation in type 2 diabetes. Methods: ...
Risk factors for peripheral artery disease and diabetic peripheral neuropathy among patients with type 2 diabetes [0.03%]
二型糖尿病患者周围动脉疾病和糖尿病外周神经病变的风险因素
Tian Chen,Shengjue Xiao,Zhengdong Chen et al.
Tian Chen et al.
Aims: To investigate the prevalence of peripheral artery disease (PAD) and diabetic peripheral neuropathy (DPN) and the associated risk factors among Chinese patients with type 2 diabetes mellitus. ...
Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study [0.03%]
GLP-1受体激动剂与其他葡萄糖降低剂对2型糖尿病和肥胖个体的心血管结局的比较：一项西班牙现实世界人群基础研究
Ana Palanca,F Javier Ampudia-Blasco,José Miguel Calderón et al.
Ana Palanca et al.
Aims: Assess the impact of glucagon-like peptide receptor agonists (GLP-1RA) compared to other glucose-lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and obesity in a Spanish metropolitan a...
Prolonged hospitalization and 1-year mortality are associated with sarcopenia and malnutrition in older patients with type 2 diabetes: A prospective cohort study [0.03%]
老年2型糖尿病患者肌肉减少症和营养不良与长期住院和1年死亡率增加相关：一项前瞻性队列研究
Mileni Vanti Beretta,Tatiana Pedroso de Paula,Ticiana da Costa Rodrigues et al.
Mileni Vanti Beretta et al.
Aim: To assess the relationship of the presence of sarcopenia and malnutrition with unfavorable clinical outcomes: prolonged length of hospital stay (LOS), readmission, and one-year mortality in older patients with type 2...
Coronary artery disease patients with rs7904519 (TCF7L2) are at a persistent risk of type 2 diabetes [0.03%]
冠心病患者携带rs7904519（TCF7L2）位点会持续增加2型糖尿病的风险
Cynthia Al Hageh,Siobhan O&#x;Sullivan,Daniel E Platt et al.
Cynthia Al Hageh et al.
Aims: Type 2 diabetes (T2D) and coronary artery disease (CAD) often coexist and share genetic factors.This study aimed to investigate the common genetic factors underlying T2D and CAD in patients with CAD. ...
Institutional experience on the impact of glucagon-like peptide-1 agonists (GLP-1) on glycemic control and weight loss in patients with type 2 diabetes at the Dubai Diabetes Center, United Arab Emirates [0.03%]
阿联酋迪拜糖尿病中心关于胰高血糖素样肽-1受体激动剂对2型糖尿病患者糖代谢及体重影响的机构经验
Dima Abdelmannan,Manal AlBuflasa,Heitham Ajlouni et al.
Dima Abdelmannan et al.
Aims: To describe the effect of three classes of GLP1 analogues on HbA1c and weight over one year in a homogenous group of patients at the Dubai Diabetes Center in Dubai, United Arab Emirates. The specific objectives are ...
Phase 3 efficacy and safety trial of proposed liraglutide biosimilar for reduction of glycosylated hemoglobin (HbA1c) in patients with Type 2 diabetes mellitus [0.03%]
利拉鲁肽类似物降低2型糖尿病患者糖化血红蛋白（HbA1c）III期疗效和安全性的试验
Kadalmani Krishnan,Srikar Raman,C R Anand Moses et al.
Kadalmani Krishnan et al.
Liraglutide is indicated for glycaemic control in adults with Type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise. A proposed biosimilar of liraglutide (Levim Liraglutide) was investigated for efficacy & safety in a phase 3 s...
Machine learning-based prediction of medication refill adherence among first-time insulin users with type 2 diabetes [0.03%]
基于机器学习的一线胰岛素使用且患有2型糖尿病的患者药物依从性预测研究
Ya-Lin Chen,Phung-Anh Nguyen,Chia-Hui Chien et al.
Ya-Lin Chen et al.
Aims: The prevalence of Type 2 Diabetes Mellitus (T2DM) is projected to be 7 % in 2030. Despite its need for long-term diabetes care, the adherence rate of injectable medications such as insulin is around 60 %, lower than...